/Investor DB

Oncology Ventures — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Modicus Primemodicusprime.comin𝕏Jul 2024 · $8M

Modicus Prime provides an AI Management System (AIMS) for pharmaceutical companies and contract development and manufacturing organizations (CDMOs) to validate, audit, and govern AI systems across their operations in compliance with FDA and other regulatory requirements.

AI & Machine LearningBiotechHealthtechSaaSLa Porte, US

Taylor Chartier(Founder & CEO)inDavit Vardanyan(Director)

BoardRoger Chen(Director)in

PartnerBen Freeberg· solo GP

Co-investorsAlumni VenturesGranatus VenturesPlug and Play VenturesSilverton PartnersSmartGateVCTechstars+4 more

OncoveryCareoncoverycare.comin𝕏May 2024

OncoveryCare develops survivorship care solutions for cancer survivors, addressing the medical and quality-of-life needs of people living after cancer treatment.

Digital HealthHealthtechMedical DevicesBoston, US

Hil Moss(Founder)inHil Moss, MBA/MPH(Co-Founder & CEO)Justin Grischkan, MD(Co-Founder & CMO)

PartnerBen Freeberg· solo GP

Co-investors.406 VenturesF-Prime CapitalFlare Capital PartnersTechstars

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.